SCHEMBL7360802

SCHEMBL7360802

Cc1cccc2c1n(Cc1cccc(C#N)c1)c(=O)n2Cc1cccc(C#N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.50
PIK3R1 P27986 3/20 0.48
PIK3CA P42336 3/20 0.48
ROCK2 O75116 1/20 0.46
BRD4 O60885 1/20 0.46
PARG Q86W56 2/20 0.45
GRIN1 Q05586 2/20 0.45
GRIN2B Q13224 2/20 0.45
CCR2 P41597 1/20 0.44
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
CFTR P13569 1/20 0.43
FEN1 P39748 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
IDH1 O75874 1/20 0.43
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8486671 0.89 ROCK2 (0.49) C5AR1PIK3R1PIK3CAROCK2BRD4
SCHEMBL8438703 0.87 C5AR1 (0.49) C5AR1PIK3R1PIK3CAPARGALDH1A1
SCHEMBL8443423 0.85 CFTR (0.52) ROCK2BRD4PARGGRIN1GRIN2B
SCHEMBL7359317 0.83 KLKB1 (0.51) PIK3R1PIK3CAROCK2BRD4PARG
SCHEMBL8438698 0.79 CCR2 (0.50) PIK3R1PIK3CAROCK2BRD4PARG
SCHEMBL8443463 0.79 CCR2 (0.53) PIK3R1PIK3CAROCK2BRD4PARG
SCHEMBL8487543 0.77 CFTR (0.54) ROCK2BRD4GRIN1GRIN2BCCR2
SCHEMBL8487078 0.77 ROCK2 (0.46) PIK3R1PIK3CAROCK2BRD4PARG
SCHEMBL8483528 0.76 GLA (0.50) PIK3R1PIK3CAROCK2BRD4PARG
SCHEMBL8439957 0.76 CFTR (0.58) ROCK2GRIN1GRIN2BCCR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863914-A ADMINISTERING TO HUMAN N,N-DIMETHYLBENZENE OR N,N-DIMETHYLNAPHTHALENE-CYCLIC UREA DERIVATIVE TO TREAT A DISEASE-STATE CAUSED BY INHIBITION OF FACTOR XA MOHAN RAJU (US) 1999-01-26 US disclosed
US-5859005-A INHIBITORS OF THROMBIN AND FACTOR XA BERLEX LABORATORIES, INC. (US) 1999-01-12 US disclosed
EP-0848708-A1 N,N-DI(ARYLMETHYL)CYCLIC UREA DERIVATIVES AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 1998-06-24 EP disclosed
US-5731308-A N,N-di(aryl) cyclic urea derivatives as anti-coagulants BERLEX LABORATORIES, INC. (US) 1998-03-24 US disclosed
US-5731311-A N,N-di(aryl) cyclic urea derivatives as anti-coagulants BERLEX LABORATORIES, INC. (US) 1998-03-24 US disclosed
US-5726173-A ANTICOAGULANTS BERLEX LABORATORIES, INC. (US) 1998-03-10 US disclosed
US-5726198-A FOR INHIBITING COAGULATION ENZYMES BERLEX LABORATORIES, INC. (US) 1998-03-10 US disclosed
US-5612363-A FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. (US) 1997-03-18 US disclosed
WO-1996038421-A1 N,N-DI(ARYLMETHYL)CYCLIC UREA DERIVATIVES AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 1996-12-05 WO disclosed